Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia

Open access
Jan, Max, Snyder, Thomas M., Corces-Zimmerman, M. Ryan, Vyas, Paresh, Weissman, Irving L., Quake, Stephen R., Majeti, Ravindra · 2012 · Science Translational Medicine

Abstract

Given that most bone marrow cells are short-lived, the accumulation of multiple leukemogenic mutations in a single clonal lineage has been difficult to explain. We propose that serial acquisition of mutations occurs in self-renewing hematopoietic stem cells (HSCs). We investigated this model through genomic analysis of HSCs from six patients with de novo acute myeloid leukemia (AML). Using exome sequencing, we identified mutations present in individual AML patients harboring the FLT3-ITD (internal tandem duplication) mutation. We then screened the residual HSCs and detected some of these mutations including mutations in the NPM1, TET2, and SMC1A genes. Finally, through single-cell analysis, we determined that a clonal progression of multiple mutations occurred in the HSCs of some AML patients. These preleukemic HSCs suggest the clonal evolution of AML genomes from founder mutations, revealing a potential mechanism contributing to relapse. Such preleukemic HSCs may constitute a cellular reservoir that should be targeted therapeutically for more durable remissions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3004315

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 721

Metadata

Authors
Jan, M., Snyder, T. M., Corces-Zimmerman, M. R., Vyas, P., Weissman, I. L., Quake, S. R., & Majeti, R.
Affiliations
  • Stanford Medicine (US)
  • Howard Hughes Medical Institute (US)
  • Program in Cancer Biology, Cancer Institute, Institute for Stem Cell Biology and Regenerative Medicine, and Ludwig Center, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
  • University of Oxford (GB)
Corresponding author
  • Jan, Max
  • Snyder, Thomas M.
  • Weissman, Irving L.
  • Quake, Stephen R.
  • Majeti, Ravindra
Venue
Science Translational Medicine
Published
2012-08-29
Volume
4
Issue
149
Pages
149ra118-149ra118
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2055521874
Cited by
721
References
49
Citations by year
2026: 12 · 2025: 22 · 2024: 31 · 2023: 44 · 2022: 43 · 2021: 51 · 2020: 51 · 2019: 62 · 2018: 56 · 2017: 68 · 2016: 79 · 2015: 79 · 2014: 75 · 2013: 40 · 2012: 7
FWCI
42.86
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (U01HL099995, U01HL099999)
  • National Cancer Institute (R01CA086065, R01CA086017)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
acute myeloid leukemia, clonal evolution, FLT3-ITD, NPM1 mutation, TET2 mutation, leukemia relapse, founder mutation, single-cell analysis, exome sequencing
MeSH terms
Nucleophosmin, Structural Maintenance of Chromosome Protein 1, Animals, Cell Separation, Chromosomal Proteins, Non-Histone, DNA Mutational Analysis, DNA-Binding Proteins, Flow Cytometry, Genetic Markers, Hematopoietic Stem Cells, Humans, Mutation, Nuclear Proteins, Phenotype, Preleukemia, Prognosis, Proto-Oncogene Proteins, Neoplastic Stem Cells, Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic, Hematopoietic Stem Cell Transplantation, Founder Effect, Cell Cycle Proteins, Cell Lineage, Genetic Predisposition to Disease, Cell Proliferation, Dioxygenases, Mice, fms-Like Tyrosine Kinase 3, Exome, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia. https://app.cochat.ai/papers/10.1126/scitranslmed.3004315
The paper
Jan, M., Snyder, T. M., Corces-Zimmerman, M. R., Vyas, P., Weissman, I. L., Quake, S. R., & Majeti, R. (2012). Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3004315

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.